• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素受体底物 2: Hippo 和 AKT 通路之间的桥梁。

Insulin receptor substrate 2: a bridge between Hippo and AKT pathways.

机构信息

National Creative Research Initiatives Center, Department of Biological Sciences, Biomedical Research Center, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.

出版信息

BMB Rep. 2018 May;51(5):209-210. doi: 10.5483/bmbrep.2018.51.5.095.

DOI:10.5483/bmbrep.2018.51.5.095
PMID:29699606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5988573/
Abstract

NAFLD induces the development of advanced liver diseases such as NASH and liver cancer. Therefore, understanding the mechanism of NAFLD development is critical for its prevention and treatment. Ablation of PTEN or Hippo pathway components induces liver cancer in a murine model by hyperactive AKT or YAP/TAZ, respectively. Although the regulation of these two pathways occurs in the same hepatocyte, the details of crosstalk between Hippo-YAP/TAZ and PTEN-AKT pathways in liver homeostasis and tumorigenesis still remain unclear. Here, we found that depletion of both PTEN and SAV1 in liver promotes spontaneous NAFLD and liver cancer through hyperactive AKT via YAP/TAZmediated up-regulation of IRS2 transcription. Conversely, NAFLD is rescued by both ablation of YAP/TAZ and activation of the Hippo pathway. Furthermore, human HCC patients with NAFLD showed strong correlation between YAP/TAZ and IRS2 or phospho-AKT expression. Finally, the inhibition of AKT by MK-2206 treatment attenuates NAFLD development and tumorigenesis. Our findings indicate that Hippo pathway interacts with AKT signaling during the intervention with IRS2 to prevent NAFLD and liver cancer. [BMB Reports 2018; 51(5): 209-210].

摘要

非酒精性脂肪性肝病(NAFLD)可诱导非酒精性脂肪性肝炎(NASH)和肝癌等晚期肝脏疾病的发生。因此,了解 NAFLD 发生发展的机制对于其预防和治疗至关重要。PTEN 或 Hippo 通路成分的缺失分别通过 AKT 或 YAP/TAZ 的过度激活在小鼠模型中诱导肝癌的发生。尽管这两条通路的调节发生在同一肝细胞中,但 Hippo-YAP/TAZ 和 PTEN-AKT 通路在肝脏稳态和肿瘤发生中的相互作用的细节仍不清楚。在这里,我们发现肝脏中同时敲除 PTEN 和 SAV1 通过 YAP/TAZ 介导的 IRS2 转录上调导致 AKT 过度激活,从而促进自发性 NAFLD 和肝癌的发生。相反,通过敲除 YAP/TAZ 和激活 Hippo 通路可挽救 NAFLD。此外,伴有 NAFLD 的人类 HCC 患者的 YAP/TAZ 和 IRS2 或磷酸化 AKT 表达之间存在强烈相关性。最后,MK-2206 抑制 AKT 的作用可减弱 NAFLD 的发生发展和肿瘤发生。我们的研究结果表明,在 IRS2 的干预下,Hippo 通路与 AKT 信号通路相互作用,以防止 NAFLD 和肝癌的发生。[BMB 报告 2018;51(5):209-210]。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d4/5988573/7b84e4bb99af/bmb-51-209f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d4/5988573/7b84e4bb99af/bmb-51-209f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75d4/5988573/7b84e4bb99af/bmb-51-209f1.jpg

相似文献

1
Insulin receptor substrate 2: a bridge between Hippo and AKT pathways.胰岛素受体底物 2: Hippo 和 AKT 通路之间的桥梁。
BMB Rep. 2018 May;51(5):209-210. doi: 10.5483/bmbrep.2018.51.5.095.
2
Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer.Hippo 通路抑制 IRS2/AKT 信号转导可预防肝脂肪变性和肝癌。
J Clin Invest. 2018 Mar 1;128(3):1010-1025. doi: 10.1172/JCI95802. Epub 2018 Feb 5.
3
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans.Hippo 级联调控小鼠和人类肝脏肿瘤的谱系决定。
Am J Pathol. 2018 Apr;188(4):995-1006. doi: 10.1016/j.ajpath.2017.12.017. Epub 2018 Jan 31.
4
PDK-1 mediated Hippo-YAP-IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells.PDK-1 介导的 Hippo-YAP-IRS2 信号通路,并参与非小细胞肺癌细胞的凋亡。
Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20182099. Print 2019 May 31.
5
Hepatoprotective Effect of Loquat Leaf Flavonoids in PM-Induced Non-Alcoholic Fatty Liver Disease via Regulation of IRs-1/Akt and CYP2E1/JNK Pathways.枇杷叶黄酮通过调节 IRS-1/Akt 和 CYP2E1/JNK 通路对 PM 诱导的非酒精性脂肪肝病的保护作用。
Int J Mol Sci. 2018 Oct 1;19(10):3005. doi: 10.3390/ijms19103005.
6
Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation.Hippo、Wnt/β-连环蛋白和Notch信号的相互作用网络抑制肝脏肿瘤形成。
BMB Rep. 2017 Jan;50(1):1-2. doi: 10.5483/bmbrep.2017.50.1.196.
7
The Hippo-YAP pathway: new connections between regulation of organ size and cancer.河马 - YAP信号通路:器官大小调控与癌症之间的新联系
Curr Opin Cell Biol. 2008 Dec;20(6):638-46. doi: 10.1016/j.ceb.2008.10.001. Epub 2008 Nov 18.
8
Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.利用 SB 转座子诱变进行非酒精性脂肪性肝病相关肝细胞癌的分子谱分析。
Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10417-E10426. doi: 10.1073/pnas.1808968115. Epub 2018 Oct 16.
9
Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation.Plk1对IRS2的磷酸化作用可通过AKT失活来防止有丝分裂过早退出。
Biochemistry. 2015 Apr 21;54(15):2473-80. doi: 10.1021/acs.biochem.5b00016. Epub 2015 Apr 6.
10
[Crosstalk of Hippo/YAP and Wnt/β-catenin pathways].[Hippo/YAP与Wnt/β-连环蛋白信号通路的相互作用]
Yi Chuan. 2014 Feb;36(2):95-102. doi: 10.3724/sp.j.1005.2014.00095.

引用本文的文献

1
Exploring drug repurposing as a therapeutic strategy for non-alcoholic fatty liver disease (NAFLD): identification of potential targets and pathways.探索药物再利用作为非酒精性脂肪性肝病(NAFLD)的治疗策略:潜在靶点和途径的鉴定
Gastroenterol Hepatol Bed Bench. 2025;18(2):230-245. doi: 10.22037/ghfbb.v18i2.3071.
2
Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.Hippo-YAP/TAZ 信号通路在肝细胞癌中的复杂作用。
J Cancer Res Clin Oncol. 2023 Nov;149(16):15311-15322. doi: 10.1007/s00432-023-05272-2. Epub 2023 Aug 22.
3
Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice.
缺乏糖异生酶 PCK1 通过激活雄性小鼠的 PI3K/AKT/PDGF 轴促进代谢相关脂肪性肝病。
Nat Commun. 2023 Mar 14;14(1):1402. doi: 10.1038/s41467-023-37142-3.
4
miR-33a Inhibits the Differentiation of Bovine Preadipocytes through the IRS2-Akt Pathway.miR-33a 通过 IRS2-Akt 通路抑制牛前体脂肪细胞的分化。
Genes (Basel). 2023 Feb 20;14(2):529. doi: 10.3390/genes14020529.
5
Network Pharmacology and Molecular Docking Study on the Multi-Target Mechanisms of for Non-Alcoholic Steatohepatitis Treatment.用于非酒精性脂肪性肝炎治疗的多靶点机制的网络药理学与分子对接研究
Plants (Basel). 2022 Dec 19;11(24):3585. doi: 10.3390/plants11243585.
6
GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress.GPx7 通过调节氧化应激改善非酒精性脂肪性肝炎。
BMB Rep. 2020 Jun;53(6):317-322. doi: 10.5483/BMBRep.2020.53.6.280.
7
PDK-1 mediated Hippo-YAP-IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells.PDK-1 介导的 Hippo-YAP-IRS2 信号通路,并参与非小细胞肺癌细胞的凋亡。
Biosci Rep. 2019 May 14;39(5). doi: 10.1042/BSR20182099. Print 2019 May 31.